Drugs / AX200
AX200
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00132470 | Dec 2004 → Mar 2007 | ischemic stroke | Axaron Bioscience AG | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AX200 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00132470 ↗ |
| Known as | G-CSF | “treatment with AX200 (granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke” NCT00132470 ↗ |
| Known as | granulocyte-colony stimulating factor | “treatment with AX200 (granulocyte-colony stimulating factor; G-CSF) for acute ischemic stroke” NCT00132470 ↗ |